Literature DB >> 2541227

Proto-oncogene analyses in brain tumors.

M Fujimoto1, P J Sheridan, Z D Sharp, F J Weaker, S Kagan-Hallet, J L Story.   

Abstract

The present study determined which oncogenes (N-myc, c-myc, v-sis, or v-fos) were amplified and which messenger ribonucleic acids (mRNA's) accumulated in 10 primary human brain tumors of neuroectodermal origin. The tumors included four glioblastomas multiforme, one mixed glioma (astrocytoma grade I and ependymoma), one astrocytoma grade II, one cystic cerebellar astrocytoma, one ependymoma, one ganglioglioma, and one medulloblastoma. The relative amounts of polyadenylated (poly(A)+) RNA's homologous to these genes and their copy number were determined using the RNA and deoxyribonucleic acid blot hybridization techniques. The N-myc and v-sis probes hybridized strongly to the poly(A)+ RNA from the same recurrent glioblastoma with gene amplifications (N-myc 80 copies; v-sis three to four copies). The c-myc probe hybridized strongly to the recurrent medulloblastoma without gene amplification. The amplification or abundant accumulation of mRNA's homologous to their oncogenes may be involved in tumorigenesis or the aggressiveness of these malignant brain tumors of neuroectodermal origin and may be good molecular indicators of an extremely malignant state in these tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541227     DOI: 10.3171/jns.1989.70.6.0910

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  11 in total

1.  Interspecies comparison of c-myc gene in human and rat glioma cell lines.

Authors:  H Shindo; E Tani; N Kochi; K Kaba; T Matsumoto; K Miyaji; Y Yamamoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

2.  Expression of TGFalpha in meningiomas.

Authors:  J Halper; C Jung; A Perry; H Suliman; M P Hill; B Scheithauer
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

3.  Stabilization of c-myc protein in human glioma cells.

Authors:  H Shindo; E Tani; T Matsumuto; T Hashimoto; J Furuyama
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

4.  Analysis of c-erbB2 protein content of human glioma cells and tumor tissue.

Authors:  H H Engelhard; M Wolters; P S Criswell
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 5.  Brain tumor hypoxia: tumorigenesis, angiogenesis, imaging, pseudoprogression, and as a therapeutic target.

Authors:  Randy L Jensen
Journal:  J Neurooncol       Date:  2009-04-09       Impact factor: 4.130

Review 6.  Genetics of primary brain tumors: a review.

Authors:  M Bondy; J Wiencke; M Wrensch; A P Kyritsis
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

Review 7.  Ependymoma.

Authors:  Charles Teo; Peter Nakaji; Patricia Symons; Vivienne Tobias; Richard Cohn; Robert Smee
Journal:  Childs Nerv Syst       Date:  2003-05-22       Impact factor: 1.475

8.  Loss of constitutional heterozygosity in chromosome 10 in human glioblastoma.

Authors:  K Watanabe; M Nagai; S Wakai; T Arai; K Kawashima
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

9.  Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis.

Authors:  Brian T Ragel; William T Couldwell; David L Gillespie; Randy L Jensen
Journal:  Neurosurg Rev       Date:  2007-05-08       Impact factor: 2.800

10.  Overexpression of multiple oncogenes related to histological grade of astrocytic glioma.

Authors:  J M Orian; K Vasilopoulos; S Yoshida; A H Kaye; C W Chow; M F Gonzales
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.